Navigation Links
Oncolytics Biotech Inc. Announces 2008 Second Quarter Results
Date:7/29/2008

1,284,955 828,602

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Our M&P expenses for the second quarter of 2008 increased to $1,284,955 compared to $828,602 for the second quarter of 2007.

In the second quarter of 2008, we completed the 40-litre production run that started earlier in the year and began the vial and packaging process. As well, we commenced an additional 40-litre production run. In the second quarter of 2007, we completed the 20-litre production runs that had been scheduled earlier in 2007.

Our process development activity in the second quarter of 2008, continues to focus on scale up to 100-litre production runs and also includes lyophilization (freeze drying) studies. In the second quarter of 2007, our process development activity focused on completing our 40-litre scale up studies.

Clinical Trial Program

2008 2007

$ $

-------------------------------------------------------------------------

Direct clinical trial expenses 1,603,171 913,360

Other clinical trial expenses 30,274 70,536

-------------------------------------------------------------------------

Clinical trial expenses 1,633,445 983,896

-------------------------------------------------------------------------

-------------------------------------------------------------------------

During the second quarter of 2008, our direct clinical trial expenses increased to $1,603,171 compared to $913,360 for the second quarter of 2007. In the second quarter of 2008, we incurred direct patient costs in our eight enrolling clinical trials compared to only six actively e
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... ... for the Structural Genomics Knowledgebase bionformatics resource , ... (PRWEB) -- The Structural Genomics Knowledgebase ... with OpenHelixTM to provide free comprehensive training and outreach programs for ...
(Date:3/17/2010)... 2010 As world population growth and dietary shifts continue, Monsanto Company,s (NYSE: ... ever before, Brett Begemann , executive vice president – seeds and traits, will tell ... will help farmers around the world meet growing global demand for grain. , ... ...
(Date:3/17/2010)... , ,, ANN ARBOR, Mich.---In findings that took the experimenters ... their collaborators have demonstrated that light itself can twist ... the current edition of Science . , Matter ... optical lenses and polarizing 3-D movie glasses. But the ...
(Date:3/17/2010)... March 17  OriGene Technologies, Inc., a leading ... $16 million Series B financing led by ... OriGene,s previous investors Morningside Venture Investments and ... round.  The proceeds from the funding will be used ...
Breaking Biology Technology:The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB) 2The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB) 3The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB) 4Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors 2Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors 3Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors 4Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors 5Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors 6Light twists rigid structures in unexpected nanotech finding 2Light twists rigid structures in unexpected nanotech finding 3OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome 2OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome 3
... N.J., Oct. 2 SyntheMed, Inc. (OTC,Bulletin Board: ... the,company,s Chairman, has assumed the newly-created position of ... the company,s clinical advisors,has assumed the newly-created position ... will be primarily involved with strategic,planning, external communications ...
... Md., Oct. 2 EntreMed, Inc.,(Nasdaq: ENMD ... treatment of cancer and inflammatory diseases, today,announced that ... Department to transfer the listing of its common ... Capital Market. The transfer will,become effective as of ...
... FOR LEAD DRUG CANDIDATE ARIKACE(TM) DRIVES,CONTINUED CLINICAL EXPANSION, ... Inc., a,biopharmaceutical company focused on developing innovative inhaled,pharmaceuticals ... announced that it has secured a $12.5 million ... Company LLC, an affiliate of Horizon,Technology Finance Management ...
Other Biology Technology:SyntheMed Announces New Management Appointments 2EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market 2EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market 3Transave, Inc. Secures $12.5 Million in New Financing 2Transave, Inc. Secures $12.5 Million in New Financing 3Transave, Inc. Secures $12.5 Million in New Financing 4Transave, Inc. Secures $12.5 Million in New Financing 5
(Date:3/17/2010)... MD (March 17, 2010) More than 1600 basic ... (fruit flies) are expected to attend the 51st ... April 7-11, 2010. , Representatives of the ... plenary, platform, poster and workshop sessions. Eligible media will ...
(Date:3/17/2010)... This release is available in French . , A ... has achieved a major breakthrough in the development of nanotubes ... diseased cells. Sleiman explains that the research involves taking DNA out ... genetic code for life, it becomes a kind of building block ...
(Date:3/17/2010)... Biosciences Institute (EBI) at the University of Illinois ... the first reported nematode survey of Miscanthus ... Lead researcher Tesfamariam Mekete, a U of I ... was to identify potential pathogenic nematodes of these ...
Breaking Biology News(10 mins):Genetics Society of America's 51st Annual Drosophila Research Conference 2Genetics Society of America's 51st Annual Drosophila Research Conference 3Genetics Society of America's 51st Annual Drosophila Research Conference 4First parasitic nematodes reported in biofuel crops 2Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 1Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 2University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 1University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 2University of Texas Picosatellite to be launched from space shuttle to begin milestone mission 12548 3First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 1First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 2First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 3First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 4First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 5
... bacterium overcomes a tomato plant,s defences and causes disease,by ... new research out today (4 December) in Current ... on a pathogen which causes bacterial speck disease,in tomato ... fruit. Severe infection can cause extensive and costly damage ...
... intake is associated with higher levels of omega-3 fatty acids ... finding of the European study IMMIDIET that will be published ... Clinical Nutriti on, an official publication of the American Society ... ). The study suggests that wine does better than ...
... new and improved tool to monitor deforestation and ... huge boost. The Gordon and Betty Moore Foundation ... Ecology with a $1.6-million grant to expand and ... a new, user-friendly method that enables even the ...
Other Biology News:Red alert! How disease disables tomato plant's 'intruder alarm' 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 3Tropical forest carbon monitoring gets big boost 2
Takara's Mutan-Super Express Km Kit is designed to achieve site-directed mutagenesis in just one day. It is based on Oligonucleotide-directed Dual Amber (ODA) method, using the advantages of LA (Long...
... The 4700 Proteomics Analyzer Mass Standards Kit ... test instrument function, optimize instrument parameters, and ... standards. This kit is designed for use ... MALDI-TOF mass spectrometry system. Standards in the ...
...
...
Biology Products: